ICM-3

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameICM-3
Drug Alias NameICM 3ICM-3
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionIntercellular adhesion molecule-1 inhibitors
TargetsIntercellular adhesion molecule-1
Therapy Area/IndicationsPsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesIcos Corporation
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIcos Corporation
Active IndicationsN/A
Inactive IndicationsPsoriasis

Other Information

ATC CodeN/A
Related LinksN/A